CX1739

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

CX1739

Specification
Cat. No.
SMD464
Related Diseases
Autism
Product Name
CX1739
Size
Customizable
Price
Inquiry
Description
CX1739 is a novel low-impact ampakine that can safely activate AMPA receptors without causing excito-neurotoxicity, rapidly crossing the blood-brain barrier, protecting against respiratory depression.
CAS Number
unknown
Chemical Formula
C13H15N3O3
Exact Mass
261.1113
Molecular Weight
261.281
Elemental Analysis
C, 59.76; H, 5.79; N, 16.08; O, 18.37
Synonym
CX1739; CX 1739; CX-1739;
IUPAC/Chemical Name
N-methyl-N-(tetrahydro-2H-pyran-4-yl)benzo[c][1,2,5]oxadiazole-5-carboxamide
InChi Key
IRYRMRDDVXULFG-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H15N3O3/c1-16(10-4-6-18-7-5-10)13(17)9-2-3-11-12(8-9)15-19-14-11/h2-3,8,10H,4-7H2,1H3
SMILES Code
O=C(C1=CC2=NON=C2C=C1)N(C)C3CCOCC3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top